Literature DB >> 27202769

A Retrospective Cost-Effectiveness Analysis of S-Amlodipine in China.

S L Hu1, Y Zhang2, J He1, L Du1.   

Abstract

Entities:  

Year:  2014        PMID： 27202769     DOI： 10.1016/j.jval.2014.08.240

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

Review 1.  S-Amlodipine: An Isomer with Difference-Time to Shift from Racemic Amlodipine.

Authors:  Jamshed Dalal; J C Mohan; S S Iyengar; Jagdish Hiremath; Immaneni Sathyamurthy; Sandeep Bansal; Dhiman Kahali; Arup Dasbiswas
Journal:  Int J Hypertens       Date:  2018-05-20       Impact factor: 2.420

2.  Efficacy and Safety of S-Amlodipine 2.5 and 5 mg/d in Hypertensive Patients Who Were Treatment-Naive or Previously Received Antihypertensive Monotherapy.

Authors:  Selçuk Şen; Meral Demir; Zerrin Yiğit; Ali Yağız Üresin
Journal:  J Cardiovasc Pharmacol Ther       Date:  2018-04-12       Impact factor: 2.457
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.